EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Endemic Region of Thiamine-Responsive Megaloblastic Anemia Caused by an SLC19A2 c.1223+1G>A Founder Mutation

Medina Gurzhikhanova iD, Sergei Fomenko, Nikolay Chekanov iD, Olga Musharova, Tatyana Salimova, Olga Goronkova, Ruslan Abasov iD, Elena Raykina, Rena Zinchenko iD, Margarita Sharova iD, Fizaliia Khisamieva, Evgeny Imyanitov iD und 5 weitere

International Journal of Molecular Sciences · 14.07.2026 · 27 (14) · 6274

DOI: 10.3390/ijms27146274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.07.2026. Verfasst von Medina Gurzhikhanova und 16 weiteren Autor:innen. Beteiligte Einrichtung: Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology, 117198 Moscow, Russia. Hauptthemen laut MEDLINE: Anemia, Megaloblastic, Membrane Transport Proteins, Hearing Loss, Sensorineural, Thiamine Deficiency. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thiamine-responsive megaloblastic anemia (TRMA) is a rare autosomal recessive disorder caused by biallelic loss of function variants in the SLC19A2 gene. It typically presents with a triad of megaloblastic anemia, diabetes mellitus, and sensorineural deafness. In this work, we analyzed ten children with suspected TRMA: nine exhibited the full triad and one, a younger sibling of a patient with full triad, did not develop hearing loss by the age of 18 months. All patients became transfusion-independent on high-dose thiamine therapy. Whole-genome sequencing identified homozygosity for the canonical splice variant SLC19A2 c.1223+1G>A in eight patients. One patient was homozygous for a known SLC19A2 c.196G>T variant, and the other was compound heterozygous for two novel variants, c.120C>G and c.584T>C. All patients with the SLC19A2 c.1223+1G>A variant were ethnic Ingush. In the reference Ingush cohort, 9/328 unrelated adults were c.1223+1G>A carriers (heterozygous carrier frequency 2.7%; carrier frequency ≈ 1/36), and shared a 2.3 Mb ATP1B1–FMO2 haplotype on chromosome 1, demonstrating a strong founder effect. These findings identify Ingushetia as a new TRMA-endemic region and support targeted SLC19A2 screening and early thiamine therapy in patients with macrocytic anemia and diabetes of unclear origin in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, MegaloblasticMembrane Transport ProteinsHearing Loss, SensorineuralThiamine DeficiencyMutationKetoglutarate Dehydrogenase ComplexDiabetes MellitusFounder EffectDiabetes Mellitus, Type 1HumansFemaleInfantMaleChild, PreschoolThiamineHomozygote

Stichwörter der Autor:innen

Rogers syndromeSLC19A2founder effectthiamine-responsive megaloblastic anemiawhole-genome sequencing

Substanzen

SLC19A2 protein, humanMembrane Transport ProteinsKetoglutarate Dehydrogenase ComplexThiamine

Autor:innen und Institutionen

  • Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology, 117198 Moscow, Russia.
  • Biotech Campus LLC, 117437 Moscow, Russia.
  • Research Centre for Medical Genetics, 115522 Moscow, Russia.
  • The State Autonomous Healthcare Institution "Children's Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan", 420064 Kazan, Russia.
  • Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, 197758 Saint Petersburg, Russia.
  • Department of Medical Genetics, St.-Petersburg Pediatric Medical University, 194100 Saint Petersburg, Russia.

ORCID-Profile: Medina Gurzhikhanova, Nikolay Chekanov, Ruslan Abasov, Rena Zinchenko, Margarita Sharova, Evgeny Imyanitov, Anna Sokolenko, Evgeny Klimuk, Konstantin Severinov, Michael Maschan

Förderung

  • Russian Science Foundation

Zitieren

APA

Gurzhikhanova, M., Fomenko, S., Chekanov, N., Musharova, O., Salimova, T., Goronkova, O., Abasov, R., Raykina, E., Zinchenko, R., Sharova, M., Khisamieva, F., Imyanitov, E., Sokolenko, A., Klimuk, E., Maschan, A., Severinov, K., & Maschan, M. (2026). An Endemic Region of Thiamine-Responsive Megaloblastic Anemia Caused by an SLC19A2 c.1223+1G>A Founder Mutation. International Journal of Molecular Sciences, 27(14), 6274. https://doi.org/10.3390/ijms27146274

Vancouver

Gurzhikhanova M, Fomenko S, Chekanov N, Musharova O, Salimova T, Goronkova O, et al. An Endemic Region of Thiamine-Responsive Megaloblastic Anemia Caused by an SLC19A2 c.1223+1G>A Founder Mutation. International Journal of Molecular Sciences. 2026;27(14):6274. doi:10.3390/ijms27146274

BibTeX
@article{Gurzhikhanova2026,
  author = {Gurzhikhanova, Medina and Fomenko, Sergei and Chekanov, Nikolay and Musharova, Olga and Salimova, Tatyana and Goronkova, Olga and Abasov, Ruslan and Raykina, Elena and Zinchenko, Rena and Sharova, Margarita and Khisamieva, Fizaliia and Imyanitov, Evgeny and Sokolenko, Anna and Klimuk, Evgeny and Maschan, Alexey and Severinov, Konstantin and Maschan, Michael},
  title = {An Endemic Region of Thiamine-Responsive Megaloblastic Anemia Caused by an SLC19A2 c.1223+1G>A Founder Mutation},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {14},
  pages = {6274},
  doi = {10.3390/ijms27146274}
}
Kostenlos starten →